Antimicrobial stewardship and drug formulary restrictions during COVID-19: what is restricted and who decides?
COVID-19 therapies were challenging to deploy due to evolving literature and conflicting guidelines. Antimicrobial stewardship can help optimize drug use. We conducted a survey to understand the role of stewardship and formulary restrictions during the pandemic. Restrictions for COVID-19 therapies w...
Saved in:
Main Authors: | Alfredo J. Mena Lora (Author), Rodrigo Burgos (Author), Scott Borgetti (Author), Lelia H. Chaisson (Author), Susan C. Bleasdale (Author) |
---|---|
Format: | Book |
Published: |
Cambridge University Press,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Remdesivir use and antimicrobial stewardship restrictions during the coronavirus disease 2019 (COVID-19) pandemic in the United States: A cross-sectional survey
by: Alfredo J. Mena Lora, et al.
Published: (2023) -
Impact of a remdesivir formulary restriction by antimicrobial stewardship on drug utilization and cost at a safety-net community hospital during the COVID-19 pandemic
by: Alfredo Jose Mena Lora, et al.
Published: (2023) -
The impact of an antimicrobial stewardship program restriction on remdesivir prescribing
by: Kristen E. Zeitler, et al.
Published: (2022) -
Levees for a hundred-year flood: impact of a syndrome-based antimicrobial stewardship intervention for coronavirus disease 2019 on antimicrobial use and resistance
by: Alfredo J. Mena Lora, et al.
Published: (2024) -
Antimicrobial Stewardship and Dose Adjustment of Restricted Antimicrobial Drugs in Hospital Setting
by: Iva Vlak, et al.
Published: (2023)